| Donny L Reeves, MD | |
|
2328 Knob Creek Rd, Suite 506, Johnson City, TN 37604-2584 | |
| (423) 722-1311 | |
| (423) 926-0529 |
| Full Name | Donny L Reeves |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 24 Years |
| Location | 2328 Knob Creek Rd, Johnson City, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558390385 | NPI | - | NPPES |
| 010089018 | Medicaid | VA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 38547 (Tennessee) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Reeves Eye Institute | 7113185406 | 3 |
News Archive
QLT Inc. today announced that QLT091001, an oral synthetic retinoid, has received positive opinions for two distinct Orphan Drug Designations by the European Medicines Agency (EMA) Committee for Orphan Medicinal Products (COMP) for the treatment of the inherited retinal degenerative diseases, Leber Congenital Amaurosis (LCA) and Retinitis Pigmentosa (RP).
Scientists at the U.S. Department of Energy's Brookhaven National Laboratory have set the stage for the rapid identification of compounds to fight against severe acquired respiratory syndrome (SARS), the atypical pneumonia responsible for about 800 deaths worldwide since first recognized in late 2002.
A new multicenter study has shown that blinded crossover and continued follow-up of trial participants can help assess vaccine durability and potential delayed enhancement of disease.
An increase in cerebral pressure may cause dementia and could destroy the brain. Companies have been seeking to find monitoring sensors that can be implanted into the brain, and read from outside the body. A tiny sensor may provide the help needed.
What keeps a newly licensed nurse on the job? Answers to that question are important to hospitals across the U.S., many of which are confronting serious nursing shortages.
› Verified 1 days ago
| Entity Name | Blue Ridge Medical Management Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144380833 PECOS PAC ID: 9739099441 Enrollment ID: O20031204000996 |
News Archive
QLT Inc. today announced that QLT091001, an oral synthetic retinoid, has received positive opinions for two distinct Orphan Drug Designations by the European Medicines Agency (EMA) Committee for Orphan Medicinal Products (COMP) for the treatment of the inherited retinal degenerative diseases, Leber Congenital Amaurosis (LCA) and Retinitis Pigmentosa (RP).
Scientists at the U.S. Department of Energy's Brookhaven National Laboratory have set the stage for the rapid identification of compounds to fight against severe acquired respiratory syndrome (SARS), the atypical pneumonia responsible for about 800 deaths worldwide since first recognized in late 2002.
A new multicenter study has shown that blinded crossover and continued follow-up of trial participants can help assess vaccine durability and potential delayed enhancement of disease.
An increase in cerebral pressure may cause dementia and could destroy the brain. Companies have been seeking to find monitoring sensors that can be implanted into the brain, and read from outside the body. A tiny sensor may provide the help needed.
What keeps a newly licensed nurse on the job? Answers to that question are important to hospitals across the U.S., many of which are confronting serious nursing shortages.
› Verified 1 days ago
| Entity Name | The Reeves Eye Institute |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306115423 PECOS PAC ID: 7113185406 Enrollment ID: O20120215000724 |
News Archive
QLT Inc. today announced that QLT091001, an oral synthetic retinoid, has received positive opinions for two distinct Orphan Drug Designations by the European Medicines Agency (EMA) Committee for Orphan Medicinal Products (COMP) for the treatment of the inherited retinal degenerative diseases, Leber Congenital Amaurosis (LCA) and Retinitis Pigmentosa (RP).
Scientists at the U.S. Department of Energy's Brookhaven National Laboratory have set the stage for the rapid identification of compounds to fight against severe acquired respiratory syndrome (SARS), the atypical pneumonia responsible for about 800 deaths worldwide since first recognized in late 2002.
A new multicenter study has shown that blinded crossover and continued follow-up of trial participants can help assess vaccine durability and potential delayed enhancement of disease.
An increase in cerebral pressure may cause dementia and could destroy the brain. Companies have been seeking to find monitoring sensors that can be implanted into the brain, and read from outside the body. A tiny sensor may provide the help needed.
What keeps a newly licensed nurse on the job? Answers to that question are important to hospitals across the U.S., many of which are confronting serious nursing shortages.
› Verified 1 days ago
| Entity Name | Reeves Eye Surgery Center Llc |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1376886887 PECOS PAC ID: 2264673037 Enrollment ID: O20130722000448 |
News Archive
QLT Inc. today announced that QLT091001, an oral synthetic retinoid, has received positive opinions for two distinct Orphan Drug Designations by the European Medicines Agency (EMA) Committee for Orphan Medicinal Products (COMP) for the treatment of the inherited retinal degenerative diseases, Leber Congenital Amaurosis (LCA) and Retinitis Pigmentosa (RP).
Scientists at the U.S. Department of Energy's Brookhaven National Laboratory have set the stage for the rapid identification of compounds to fight against severe acquired respiratory syndrome (SARS), the atypical pneumonia responsible for about 800 deaths worldwide since first recognized in late 2002.
A new multicenter study has shown that blinded crossover and continued follow-up of trial participants can help assess vaccine durability and potential delayed enhancement of disease.
An increase in cerebral pressure may cause dementia and could destroy the brain. Companies have been seeking to find monitoring sensors that can be implanted into the brain, and read from outside the body. A tiny sensor may provide the help needed.
What keeps a newly licensed nurse on the job? Answers to that question are important to hospitals across the U.S., many of which are confronting serious nursing shortages.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Donny L Reeves, MD Po Box 6015, Johnson City, TN 37602-6015 Ph: (423) 722-1311 | Donny L Reeves, MD 2328 Knob Creek Rd, Suite 506, Johnson City, TN 37604-2584 Ph: (423) 722-1311 |
News Archive
QLT Inc. today announced that QLT091001, an oral synthetic retinoid, has received positive opinions for two distinct Orphan Drug Designations by the European Medicines Agency (EMA) Committee for Orphan Medicinal Products (COMP) for the treatment of the inherited retinal degenerative diseases, Leber Congenital Amaurosis (LCA) and Retinitis Pigmentosa (RP).
Scientists at the U.S. Department of Energy's Brookhaven National Laboratory have set the stage for the rapid identification of compounds to fight against severe acquired respiratory syndrome (SARS), the atypical pneumonia responsible for about 800 deaths worldwide since first recognized in late 2002.
A new multicenter study has shown that blinded crossover and continued follow-up of trial participants can help assess vaccine durability and potential delayed enhancement of disease.
An increase in cerebral pressure may cause dementia and could destroy the brain. Companies have been seeking to find monitoring sensors that can be implanted into the brain, and read from outside the body. A tiny sensor may provide the help needed.
What keeps a newly licensed nurse on the job? Answers to that question are important to hospitals across the U.S., many of which are confronting serious nursing shortages.
› Verified 1 days ago
Dr. John Clifford Johnson, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 110 Med Tech Pkwy, Suite 1, Johnson City, TN 37604 Phone: 423-929-2111 Fax: 423-929-0497 | |
Jennifer Oakley, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 110 Med Tech Pkwy, Suite 1, Johnson City, TN 37604 Phone: 423-929-2111 Fax: 423-929-0497 | |
Michael Farzin Shahbazi, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 110 Med Tech Pkwy, Suite 1, Johnson City, TN 37604 Phone: 423-929-2111 Fax: 423-929-0497 | |
Alan N Mccartt, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 110 Med Tech Pkwy, Suite 1, Johnson City, TN 37604 Phone: 423-929-2111 Fax: 423-929-0497 | |
Amy B Young, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 110 Med Tech Pkwy, Suite 1, Johnson City, TN 37604 Phone: 423-929-2111 Fax: 423-929-0497 | |
Calvin L Miller, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 110 Med Tech Pkwy, Johnson City, TN 37604 Phone: 423-722-0360 Fax: 423-793-1339 | |
Dr. James W Battle Iii, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 110 Med Tech Pkwy, Suite 1, Johnson City, TN 37604 Phone: 423-929-2111 Fax: 423-929-0497 |